# Observational Study of Immune Response to Hepatitis B Childhood Booster

> **NCT00873652** · — · COMPLETED · sponsor: **University of Oxford** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Engerix B®, a recombinant hepatitis B vaccine

## Key facts

- **NCT ID:** NCT00873652
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873652, "Observational Study of Immune Response to Hepatitis B Childhood Booster". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00873652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*